If this translates to billions of users, with 50% or more being women or non-binary persons, then deficits in our understanding of how SBV impacts safety, efficacy, and quality of phytomedicines are highly significant problems.
← all excerpts
Evidence and Tradition in Dialogue: Biological Sex Variability in Phytomedicine Research as a Foundation for Safety, Efficacy, and Robust Evidence Standards.
1
—
—